Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis
about
TMC207 for treatment of people with pulmonary tuberculosisFluoroquinolones for treating tuberculosis (presumed drug-sensitive)New Antituberculosis Drugs: From Clinical Trial to Programmatic UsePET/CT imaging of Mycobacterium tuberculosis infectionManagement of multidrug-resistant TB: novel treatments and their expansion to low resource settingsPsycho-Socio-Economic Issues Challenging Multidrug Resistant Tuberculosis Patients: A Systematic ReviewEffects of Fluroquinolones in Newly Diagnosed, Sputum-Positive Tuberculosis Therapy: A Systematic Review and Network Meta-AnalysisMedical Management of Drug-Resistant TuberculosisExtensively drug-resistant tuberculosis: epidemiology and managementTreatment outcomes from community-based drug resistant tuberculosis treatment programs: a systematic review and meta-analysisNew developments in the treatment of drug-resistant tuberculosis: clinical utility of bedaquiline and delamanidAssociation between Directly Observed Therapy and Treatment Outcomes in Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-AnalysisAssociation between diabetes mellitus and multi-drug-resistant tuberculosis: a protocol for a systematic review and meta-analysisCharacteristics and treatment outcomes of patients with MDR and XDR tuberculosis in a TB referral hospital in Beijing: a 13-year experienceAmbulatory multi-drug resistant tuberculosis treatment outcomes in a cohort of HIV-infected patients in a slum setting in Mumbai, IndiaOutcomes of multi-drug resistant tuberculosis (MDR-TB) among a cohort of South African patients with high HIV prevalenceRifampicin for continuation phase tuberculosis treatment in Uganda: a cost-effectiveness analysisAdverse events among HIV/MDR-TB co-infected patients receiving antiretroviral and second line anti-TB treatment in Mumbai, IndiaResearch questions and priorities for tuberculosis: a survey of published systematic reviews and meta-analysesMultidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patientsAggressive regimens for multidrug-resistant tuberculosis decrease all-cause mortalityRisk factors associated with default from multi- and extensively drug-resistant tuberculosis treatment, Uzbekistan: a retrospective cohort analysisRisk factors for poor treatment outcomes in patients with MDR-TB and XDR-TB in China: retrospective multi-center investigationAlcohol, hospital discharge, and socioeconomic risk factors for default from multidrug resistant tuberculosis treatment in rural South Africa: a retrospective cohort studyA multi-site validation in India of the line probe assay for the rapid diagnosis of multi-drug resistant tuberculosis directly from sputum specimensLoss from treatment for drug resistant tuberculosis: risk factors and patient outcomes in a community-based program in Khayelitsha, South AfricaGood quality locally procured drugs can be as effective as internationally quality assured drugs in treating multi-drug resistant tuberculosisGenoType MTBDRplus Assay for Rapid Detection of Multidrug Resistance in Mycobacterium tuberculosis: A Meta-Analysis"When Treatment Is More Challenging than the Disease": A Qualitative Study of MDR-TB Patient RetentionMDR-TB Outbreak among HIV-Negative Tunisian Patients followed during 11 YearsClinical Features and Treatment Outcomes of Patients with Drug-Resistant and Drug-Sensitive Tuberculosis: A Historical Cohort Study in Porto Alegre, BrazilBibliometric analysis of worldwide publications on multi-, extensively, and totally drug - resistant tuberculosis (2006-2015)MDR-TB treatment as prevention: The projected population-level impact of expanded treatment for multidrug-resistant tuberculosisA systematic follow-up of Mycobacterium tuberculosis drug-resistance and associated genotypic lineages in the French Departments of the Americas over a seventeen-year period[Resistance to first-line drugs and major genotypic lineages of Mycobacterium tuberculosis in the 3 French Department of the Americas: Profiles, evolution, and trends (1995-2011)].Multidrug-Resistant TB: Implementing the Right to Health through the Right to Enjoy the Benefits of Scientific Progress.Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysis.Treatment outcomes of patients with multidrug-resistant and extensively drug-resistant tuberculosis according to drug susceptibility testing to first- and second-line drugs: an individual patient data meta-analysis.Sputum culture conversion as a prognostic marker for end-of-treatment outcome in patients with multidrug-resistant tuberculosis: a secondary analysis of data from two observational cohort studies.Treatment outcome of standardized regimen in patients with multidrug resistant tuberculosis.
P2860
Q24199155-68471CCD-A9CB-43BF-A34A-36CBAA234568Q24202081-4BCD9476-9601-441D-B423-507EA61FDB3EQ26741138-F9299FE3-2CE7-4E2B-8957-A98C4B5CD02CQ26748493-1A3F71AF-0FE3-43A7-A465-95B526C82A19Q26765394-AEADC6FD-E6C1-4312-835C-FC75F2F81F33Q26774846-505D4D38-B4FC-4F74-83C3-5F50DC2F925AQ26775757-B8E7712D-D567-43F2-B943-CC006DDBFAF7Q26801601-2CADF2D5-32D6-4B1B-8F42-DA2464CF8B5BQ26830094-EC13F349-95BE-48FF-B777-6BE43F91AE68Q26999537-0468287D-111E-44A1-BE09-C56F6B92231AQ27003210-5C94FE3D-1B10-4F32-BBCF-FEFAE04A65DFQ27013703-AE8319B7-4BF6-495F-945E-6AAEB2C69594Q28468566-3AC44436-1A22-44E3-962C-65C575308F6FQ28478005-1FC9C40B-324C-42F6-A173-2E915DCC5AD4Q28478204-9C2CFDEF-02F9-45F0-AC59-BF2B48F2E23BQ28479241-9457A856-E33B-4762-A7DE-914D3DDE92ABQ28480467-3FDC10A7-9FD2-4444-915A-AB0C93D7C388Q28481249-0A6AEE36-1594-41DB-94E9-7CBF48DD6F3CQ28481610-311A26C7-B9A8-45E7-BFC7-F9A381A1E63DQ28482730-B1BD7CA0-E19D-4F20-A460-A5770DA93CD3Q28487938-2C8C815D-F00D-4C36-9754-C4DC523EEAD9Q28534902-ED3AEAAE-D393-4A38-B517-B55B74BC3603Q28536653-691B6328-2C91-43E4-A856-A3A0472EB453Q28537696-264F329D-60C0-4C85-BA79-449C7A11B610Q28539890-E53874F4-C442-46D3-9DDC-F118792EF0D3Q28544642-32DB41AB-1A2F-408F-9906-3A1AC912FA35Q28546831-CA7C7F6D-43F4-4A59-8810-CC3079642651Q28550477-8F568300-3F8A-4E1F-842D-5191D0F3D133Q28550630-850714CD-D713-4DB6-B102-9D56919DD14DQ28551671-EC3736A3-BF54-42C3-AE2C-53FA1C54E161Q28553427-B98D240B-EB57-4E15-A85D-7C39D8E533F8Q28555235-E1ED892B-95B0-4A4F-A083-214AF40DE875Q29247878-1A5E7ADA-8E04-4C6E-8294-D5A3980AA1C9Q29353709-5B3315A3-EE9B-45BD-93A7-7D6D131BAEC2Q29353712-FC9BA144-DBF0-42A2-84AF-2A49FE491464Q30380955-EB0197B0-DE2D-4258-993F-D2C9C39BF395Q30573127-150EEBA4-0CF0-4482-B1FA-F9EF7C6642B0Q30840887-E84006E3-1E9B-4E3B-8FD1-A6B02AFBCAE1Q30901894-E7F0D78D-97F5-449A-BCD7-32AD4B86C5A3Q33561777-15D8DB3D-7B82-40CC-9277-B9F3C061B6D3
P2860
Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Treatment outcomes of multidru ...... matic review and meta-analysis
@ast
Treatment outcomes of multidru ...... matic review and meta-analysis
@en
Treatment outcomes of multidru ...... matic review and meta-analysis
@nl
type
label
Treatment outcomes of multidru ...... matic review and meta-analysis
@ast
Treatment outcomes of multidru ...... matic review and meta-analysis
@en
Treatment outcomes of multidru ...... matic review and meta-analysis
@nl
prefLabel
Treatment outcomes of multidru ...... matic review and meta-analysis
@ast
Treatment outcomes of multidru ...... matic review and meta-analysis
@en
Treatment outcomes of multidru ...... matic review and meta-analysis
@nl
P2860
P31
P921
P3181
P1433
P1476
Treatment outcomes of multidru ...... matic review and meta-analysis
@en
P2093
J Mark Fitzgerald
James C Johnston
P2860
P3181
P356
10.1371/JOURNAL.PONE.0006914
P407
P5008
P577
2009-09-09T00:00:00Z